Pricing Log in Create free account
Friday 6 November 2026 Export ACHC’s income statement to Excel — free account

Acadia Healthcare Company, Inc.

ACHC Healthcare Medical Care Facilities

Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024.

Revenue
+5.14%
EPS
−5.00%
Free cash flow
+196.5%
Total debt
+1.87%

Quarter to September 2026, against a year earlier

34.86 2.61 +8.09%
Market cap
$3.2B
P/E
0.0×
Fwd P/E
34.4×
Dividend yield
—
F-score
5/9
Altman Z
0.92
Beneish M
−3.58
Dividend safety
2/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 4.21%

Capital & Financial Ratios $m

Size
Market Cap 3,240.00
Revenue ttm 3,411.41
Net income ttm (1,121.87)
Free cash flow ttm 10.74
Net debt Q 2,189.05
Valuation
P/E 0.00
Forward P/E 34.40
Price / sales 0.93
Forward P/S Powerpack
Price / FCF 295.12
Price / book 1.57
Financial health
Current ratio Q 1.60 (at or above 1.5: strong)
Debt / equity Q 1.16
Interest coverage Q 0.00
Growth
Revenue growth Q +5.14% (above 0%: growing)
Operating income growth Q −38.32% (below 0%: shrinking)
EPS, this year −15.72% (below 0%: weak)
EPS, next year A +15.54% (at or above 15%: strong)
Revenue, next year A +3.48%
EPS, past 5 yrs —
EPS, next 5 yrs A +4.72%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.6×, against a ten-year median of 2.8×; over the ten years it ranged from 1.1× in 2026 to 5.3× in 2020.
P/S against its own 10 years 17.16%
10-year low 10-year high
P/B against its own 10 years 50.83%
10-year low 10-year high
EV/Sales against its own 10 years 15.33%
10-year low 10-year high
EV/FCF against its own 10 years 98.21%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 100 76 133 163
Receivables 361 365 441 501
Inventory — — — —
Other 134 136 240 217
596 577 814 881
2023 2024 2025 Q'26
Payables 156 233 150 139
ST’ Debt 29 77 28 33
Other — — — —
886 578 525 552

Compound Annual Growth %

10y 5y 3y
Sales 6.32% 9.65% 8.27%
Cash Flow (5.83%) (27.51%) (29.76%)
Earnings 0.00% 0.00% 0.00%
Book Value 1.48% 0.52% (11.51%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.46 Actual 0.60

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.03 0.07 Beat by 0.04
Q1 FY26 0.28 0.37 Beat by 0.09
Q2 FY26 0.33 0.38 Beat by 0.05
Q3 FY26 0.46 0.60 Beat by 0.14
Q4 FY26 0.35 — Reports 24 February 2027

EPS $

Mar Jun Sep Dec Year
’26 0.05 0.12 0.38 — —
’25 0.09 0.33 0.40 (13.02) (12.16)
’24 0.83 0.85 0.74 0.35 2.78
’23 0.72 0.79 (2.39) 0.63 (0.24)
’22 0.67 0.88 0.78 0.67 2.98
’21 0.11 0.49 0.73 0.77 2.10
’20 0.38 0.46 0.42 (8.78) (7.59)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 829 866 895 — —
’25 771 869 852 821 3,313
’24 768 796 816 774 3,154
’23 704 731 750 743 2,929
’22 617 652 667 675 2,610
’21 551 582 588 593 2,314
’20 509 491 548 541 2,090
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 62 162 98 — —
’25 11 134 73 (86) 132
’24 (321) 171 163 117 130
’23 44 164 138 116 462
’22 77 149 41 114 381
’21 76 90 110 98 374
’20 46 219 207 187 659
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 1 134 55 — —
’25 (163) (18) (57) (179) (416)
’24 (455) 18 (27) (87) (550)
’23 (22) 73 10 6 68
’22 28 68 (35) 31 91
’21 17 37 67 11 133
’20 (13) 164 153 130 434
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 2,811 2,836 1,905 2,008 2,090 2,314 2,610 2,929 3,154 3,313 3,411 +1.8% 3,428 3,628 3,815 +4.8%
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.0 pt
EBT 33 237 67 78 184 276 374 (25) 342 (1,066) (1,080) n/m
EBT margin, % 1.17 8.35 3.54 3.90 8.79 11.91 14.33 (0.87) 10.84 (32.18) (31.66) (33.3) pt
Net income 4 200 (175) 110 (669) 196 280 (16) 264 (1,092) (1,122) n/m
Per share, $
Per share, $ Revenue 32.80 32.62 21.82 22.92 23.78 26.07 29.11 32.20 34.42 36.52 37.53 +1.2%
Earnings 0.07 2.30 (2.01) 1.24 (7.65) 2.15 3.05 (0.24) 2.79 (12.16) (12.47) n/m
Cash flow 4.22 4.60 4.74 3.80 7.50 4.22 4.24 5.08 1.42 1.45 2.59 (11.2%)
Capex (4.06) (3.57) (3.11) (2.52) (2.56) (2.72) (3.22) (4.34) (7.42) (6.04) (2.47) +4.5%
Free cash flow 0.15 1.03 1.63 1.28 4.94 1.50 1.02 0.74 (6.01) (4.59) 0.12 n/m
Book value 25.29 29.59 26.73 28.60 21.62 28.36 31.36 30.59 33.55 21.49 22.25 (1.8%)
Shares, m 86 87 87 88 88 89 90 91 92 91 91 +0.6%
Valuation, ×
Valuation, × P/E 411.13 14.76 0.00 26.58 0.00 28.36 26.80 0.00 14.16 0.00 0.00 52.2
P/S 1.00 1.04 1.18 1.45 2.12 2.33 2.80 2.43 1.15 0.39 0.93 1.6
P/B 1.30 1.14 0.96 1.16 2.33 2.14 2.60 2.56 1.18 0.66 1.57 1.6
EV/Sales 2.15 2.16 2.83 2.97 3.43 2.92 3.29 2.86 1.75 1.10 1.57 2.5
EV/FCF 456.60 68.22 37.80 53.22 16.51 50.70 93.94 124.05 (10.02) (8.78) 499.01 88.2
Cash, $m
Cash, $m Operating cash flow 361 400 414 333 659 374 381 462 130 132 235 (10.6%)
Capex (348) (310) (272) (221) (225) (241) (289) (395) (680) (548) (224) +5.2%
Free cash flow 13 90 143 112 434 133 91 68 (550) (416) 11 n/m
Balance, $m
Balance, $m Working capital 85 94 34 79 1,215 90 118 (290) 0 289 329 +14.6%
Net debt 3,231 3,173 3,143 3,050 2,744 1,363 1,288 1,272 1,881 2,367 2,189 (3.4%)
Shareholders’ equity 2,168 2,573 2,333 2,505 1,899 2,517 2,813 2,782 3,074 1,949 2,022 (1.2%)
Returns, %
Returns, % ROA 0.12 3.21 (2.79) 1.67 (10.05) 3.38 5.60 (0.42) 4.52 (19.20) (18.85) (19.3) pt
ROIC 5.15 4.76 3.49 3.53 4.92 6.67 7.13 7.91 6.59 5.62 0.00 +0.5 pt
ROE 0.32 8.43 (7.16) 4.50 (30.52) 8.63 10.25 (0.77) 8.73 (43.91) (43.87) (44.2) pt
People
People Employees 40,400 40,600 42,100 42,800 42,200 22,500 23,000 23,500 25,500 25,000 — (5.2%)
Revenue/emp, $m 0.07 0.07 0.05 0.05 0.05 0.10 0.11 0.12 0.12 0.13 — +7.4%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 4 Nov 2026

Acadia Healthcare Company, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NHC National HealthCare Corporation $3.3B 28.2× 8.4× +6.61% (above 0%: growing) −65.61% (below 0%: shrinking) +75.52% (above 0%: growing) 100.00% 0.00% Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00%
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
BKD Brookdale Senior Living Inc. $2.6B — (loss-making) 341× −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86% Compare
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.8× 33.3× −1.68% (below 0%: shrinking) +133.33% (above 0%: growing) +88.88% (above 0%: growing) 22.97% 6.75% Compare
MD Pediatrix Medical Group, Inc. $2.5B 17.1× 15.3× +1.72% (above 0%: growing) −27.61% (below 0%: shrinking) −14.41% (below 0%: shrinking) 27.98% 13.01% Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27% Compare
ASTH Astrana Health, Inc. $1.9B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
Median of peers $2.6B 24.6× 20.3× +4.68% +35.17% +21.74% 28.96% 11.07%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 25 March 2026

Ownership

Directors and executive officers, together 1.20%
Wellington Management Group LLC 12.80%
BlackRock, Inc. 11.20%
The Vanguard Group 10.20%
Khrom Capital Management LLC 8.10%
FMR LLC 6.80%
The Goldman Sachs Group, Inc. 5.10%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Acadia Healthcare Company, Inc. (ACHC) Latest News

5 Nov

Impact 3 · · GuruFocus.com
Impact 3 · · The Motley Fool transcript
Impact 3 · · MarketBeat transcript
Impact 3 · · Moby

4 Nov

Impact 3 · · Associated Press
Impact 3 · · StockStory
Impact 3 · · Business Wire

17 Oct

Impact 3 · · Simply Wall St.
Impact 3 · · Simply Wall St.

8 Oct

Impact 3 · · Zacks

7 Oct

Impact 3 · · StockStory

5 Oct

Impact 3 · · Zacks
Impact 3 · · Zacks

25 Sep

Impact 3 · · Business Wire

22 Sep

Impact 4 · · Zacks
Impact 4 ·

17 Sep

Impact 3 ·

30 Jul

Impact 4 ·
Impact 3 ·

29 Jul

Impact 3 · transcript
Impact 3 · · MarketBeat
Impact 3 ·

28 Jul

Impact 4 ·
Impact 3 ·
Impact 3 ·

23 Jun

Impact 3 · · Zacks

15 Jun

Impact 3 ·

5 Jun

Impact 3 · · Insider Monkey

1 Jun

Impact 3 · · Simply Wall St.

10 May

Impact 4 · · Insider Monkey

ACHC metrics, ten years each

stockrow.com/ACHC · Data as of Nov 4, 2026 · For information only; not investment advice. · © 2026 stockrow.com